日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors

一项针对晚期或转移性实体瘤患者的溶瘤病毒ASP9801的1期开放标签研究

Villano, John L; Luke, Jason J; Julian, Ricklie; Fountzilas, Christos; Patel, Manish R; Chisamore, Michael J; Bhattacharya, Pranob; Takeshita, Shigeru; Soukharev, Serguei; Yamada, Shunsuke; Zhang, Leshi; Wentzel, Kristopher P

Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathway

通过 HLA-G/ILT2/ILT4 通路释放先天生物学的潜力

Beers, Courtney; Ilaria, Robert L; Luke, Jason J

Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma: A Secondary Analysis of a Randomized Clinical Trial

帕博利珠单抗辅助治疗IIB期或IIC期黑色素瘤:一项随机临床试验的二次分析

Leachman, Sancy A; Luke, Jason J; Ascierto, Paolo A; Long, Georgina V; Khattak, Muhammad A; Rutkowski, Piotr; Xu, Zhi Jin; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Eggermont, Alexander M M; Schadendorf, Dirk

Author Correction: Autologous T cell therapy for PRAME(+) advanced solid tumors in HLA-A*02(+) patients: a phase 1 trial

作者更正:自体T细胞疗法治疗HLA-A*02(+)患者的PRAME(+)晚期实体瘤:一项I期试验

Wermke, Martin; Araujo, Dejka M; Chatterjee, Manik; Tsimberidou, Apostolia M; Holderried, Tobias A W; Jazaeri, Amir A; Reshef, Ran; Bokemeyer, Carsten; Alsdorf, Winfried; Wetzko, Katrin; Brossart, Peter; Aslan, Katrin; Backert, Linus; Bunk, Sebastian; Fritsche, Jens; Gulde, Swapna; Hengler, Silvana; Hilf, Norbert; Hossain, Mohammad B; Hukelmann, Jens; Kalra, Mamta; Krishna, Delfi; Kursunel, M Alper; Maurer, Dominik; Mayer-Mokler, Andrea; Mendrzyk, Regina; Mohamed, Ali; Pozo, Karine; Satelli, Arun; Letizia, Marilena; Schuster, Heiko; Schoor, Oliver; Wagner, Claudia; Rammensee, Hans-Georg; Reinhardt, Carsten; Singh-Jasuja, Harpreet; Walter, Steffen; Weinschenk, Toni; Luke, Jason J; Britten, Cedrik M

Autologous T cell therapy for PRAME(+) advanced solid tumors in HLA-A*02(+) patients: a phase 1 trial

自体T细胞疗法治疗HLA-A*02(+)患者的PRAME(+)晚期实体瘤:一项I期试验

Wermke, Martin; Araujo, Dejka M; Chatterjee, Manik; Tsimberidou, Apostolia M; Holderried, Tobias A W; Jazaeri, Amir A; Reshef, Ran; Bokemeyer, Carsten; Alsdorf, Winfried; Wetzko, Katrin; Brossart, Peter; Aslan, Katrin; Backert, Linus; Bunk, Sebastian; Fritsche, Jens; Gulde, Swapna; Hengler, Silvana; Hilf, Norbert; Hossain, Mohammad B; Hukelmann, Jens; Kalra, Mamta; Krishna, Delfi; Kursunel, M Alper; Maurer, Dominik; Mayer-Mokler, Andrea; Mendrzyk, Regina; Mohamed, Ali; Pozo, Karine; Satelli, Arun; Letizia, Marilena; Schuster, Heiko; Schoor, Oliver; Wagner, Claudia; Rammensee, Hans-Georg; Reinhardt, Carsten; Singh-Jasuja, Harpreet; Walter, Steffen; Weinschenk, Toni; Luke, Jason J; Britten, Cedrik M

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma

遗传性线粒体基因作为黑色素瘤免疫检查点抑制剂疗效的预测因子

Monson, Kelsey R; Ferguson, Robert; Handzlik, Joanna E; Morales, Leah; Xiong, Jiahan; Chat, Vylyny; Dagayev, Sasha; Khodadadi-Jamayran, Alireza; Simpson, Danny; Kazlow, Esther; Bunis, Anabelle; Sreenivasaiah, Chaitra; Ibrahim, Milad; Voloshyna, Iryna; Ouwerkerk, Wouter; Luiten, Rosalie M; Capone, Mariaelena; Madonna, Gabriele; Lu, Yuting; Shao, Yongzhao; Pavlick, Anna; Krogsgaard, Michelle; Mehnert, Janice; Tang, Hao; Dolfi, Sonia; Tenney, Daniel; Haanen, John B A G; Gajewski, Thomas F; Hodi, F Stephen; Flaherty, Keith T; Couts, Kasey; Robinson, William; Puzanov, Igor; Ernstoff, Marc S; Rahma, Osama; Postow, Michael; Sullivan, Ryan J; Luke, Jason J; Ascierto, Paolo A; Osman, Iman; Kirchhoff, Tomas

Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancers.

精准靶向β-catenin可诱导肝细胞癌的肿瘤重编程和免疫反应

Lehrich Brandon M, Delgado Evan R, Yasaka Tyler M, Liu Silvia, Cao Catherine, Liu Yuqing, Taheri Mohammad N, Guan Xiangnan, Koeppen Hartmut, Singh Sucha, Meadows Vik, Liu Jia-Jun, Singh-Varma Anya, Krutsenko Yekaterina, Poddar Minakshi, Hitchens T Kevin, Foley Lesley M, Liang Binyong, Rialdi Alex, Rai Ravi P, Patel Panari, Riley Madeline, Bell Aaron, Raeman Reben, Dadali Tulin, Luke Jason J, Guccione Ernesto, Ebrahimkhani Mo R, Lujambio Amaia, Chen Xin, Maier Martin, Wang Yulei, Broom Wendy, Tao Junyan, Monga Satdarshan P

NCOG-33. The Cognitive Sequelae of Immunotherapy: Initial Results from A Longitudinal Prospective Study in Patients with Solid Malignancies

NCOG-33. 免疫疗法的认知后遗症:一项针对实体恶性肿瘤患者的纵向前瞻性研究的初步结果

Kokenberger, Grant; Singh, Jatin; Hurd, Drew; Yu, Tong; Meng, Xin; Nguyen, Madison; Storkus, Walter J; McKay, William; Luke, Jason J; Najjar, Yana G; Kirkwood, John M; Zarour, Hassane M; Davar, Diwakar; Pu, Jiantao; Tschernichovsky, Roi Roi; Amiel, Alexandra; Siegal, Tali; Katz, Shlomit Yust

A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy

SITC愿景:调整临床试验以加速癌症免疫疗法药物的研发

Marron, Thomas U; Luke, Jason J; Hoffner, Brianna; Perlmutter, Jane; Szczepanek, Connie; Anagnostou, Valsamo; Silk, Ann W; Romero, Pedro J; Garrett-Mayer, Elizabeth; Emens, Leisha A

Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors

STING激动剂E7766治疗晚期实体瘤的I期剂量递增和药效学研究

Luke, Jason J; Pinato, David J; Juric, Dejan; LoRusso, Patricia; Hosein, Peter J; Desai, Anupam M; Haddad, Robert; de Miguel, María; Cervantes, Andrés; Kim, Won Seog; Marabelle, Aurélien; Zhang, Yan; Rong, Yuanxin; Yuan, Xiaobin; Champiat, Stéphane